Real-time enrollment status for this igan clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:52 AM UTC
| NCT Number | NCT06989359 |
| Recruiting Status | Recruiting |
| Condition | IgAN |
| Phase | PHASE2 |
| Target Enrollment | 45 participants |
| Active Locations | 11 sites in the US |
| Sponsor | ADARx Pharmaceuticals, Inc. |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of August 28, 2026: Clinical trial NCT06989359 is currently recruiting participants. This phase2 study for igan is actively seeking new participants at 11 locations across the United States. The study is sponsored by ADARx Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06989359 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06989359 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.